TY  - JOUR
AU  - Teipel, Stefan
AU  - Tang, Yi
AU  - Boccardi, Marina
TI  - Predicting cognitive decline in older people by structural and molecular imaging.
JO  - Current opinion in neurology
VL  - 36
IS  - 4
SN  - 1350-7540
PB  - Ovid
M1  - DZNE-2023-00727
SP  - 253 - 263
PY  - 2023
AB  - Availability of possible disease modifying treatments and the recognition of predementia stages of Alzheimer's disease (AD) have raised awareness for the prognostic and predictive role of biomarkers, particularly imaging markers.The positive predictive value of amyloid PET for the transition to prodromal AD or AD dementia in cognitively normal people is below 25
KW  - Humans
KW  - Aged
KW  - Fluorodeoxyglucose F18
KW  - Alzheimer Disease: diagnostic imaging
KW  - Cognitive Dysfunction: diagnostic imaging
KW  - Prognosis
KW  - Positron-Emission Tomography: methods
KW  - Biomarkers
KW  - Molecular Imaging
KW  - Amyloid beta-Peptides
KW  - tau Proteins
KW  - Fluorodeoxyglucose F18 (NLM Chemicals)
KW  - Biomarkers (NLM Chemicals)
KW  - Amyloid beta-Peptides (NLM Chemicals)
KW  - tau Proteins (NLM Chemicals)
LB  - PUB:(DE-HGF)16
C6  - pmid:37382114
DO  - DOI:10.1097/WCO.0000000000001172
UR  - https://pub.dzne.de/record/259131
ER  -